ECOLOGY AND WILDLIFE: Pharmed Fish by Betts, Kellyn S.
ecology and wildlife 
Pharmed Fish
Results from a recent pilot study of the uptake 
of pharmaceuticals and personal care products 
(PPCPs) by fish in U.S. rivers have garnered 
considerable  attention  since  they  were  pub­
lished online 25 March 2009 ahead of print in 
Environmental Toxicology and Chemistry. The 
study, led by Baylor University chemistry pro­
fessor C. Kevin Chambliss and environmental 
science  professor  Bryan  Brooks,  broke  new 
ground by assessing chemical contamination of 
wild fish at a variety of sampling sites, screening 
a relatively large and diverse array of PPCPs. 
The  work  focused  on  five  rivers  in 
Chicago, Dallas, Orlando, Phoenix, and West 
Chester  (Pennsylvania)  that  receive  waste­
water directly from treatment facilities. All five 
rivers  are  considered  “effluent­dominated” 
because the high volume of wastewater they 
receive  continuously  exposes  their  aquatic 
inhabitants to effluent­derived con­
taminants. “Such [worst­case] expo­
sure  scenarios  are  not  represented 
in  standardized  toxicity  tests  used 
to assess ecological risk of PPCPs to 
aquatic life,” Chambliss and Brooks 
point out in their paper.
The researchers screened samples 
of  fish  fillet  (muscle  and  skin)  for 
24 pharmaceuticals and 12 personal 
care products, while samples of fish 
liver  were  screened  for  pharmaceu­
ticals  only.  The  team  found  levels 
of 7 pharmaceuticals and 2 personal 
care  products  above  method  detec­
tion limits in the tissues analyzed (see 
table). This is the first report of the 
presence of the lipid regulator gem­
fibrozil in U.S. wild fish. 
The  team  explained  that  they 
chose  the  study  sites  because  point 
source  discharges  from  wastewater 
treatment  facilities  are  “the  most 
significant  entry  route  for  human 
pharmaceuticals into the aquatic envi­
ronment.” However, recent work by 
Joakim Larsson, an assistant professor 
at Göteborg University, published in 
the  April  2009  issue  of  Regulatory 
Toxicology  and  Pharmacology  suggest 
pharmaceutical manufacturing plants 
in  the  developing  world  can  release 
much higher quantities into the nearby 
environment. Larsson says the impact 
of  wastewater  from  pharmaceutical 
manufacturers in the developed world 
is not yet clear, but a 19 April 2009 Associated 
Press story reports that unpublished data from 
the U.S. Geological Survey (USGS) and the 
U.S Environmental Protection Agency (EPA) 
show U.S. plants also may emit high concen­
trations of pharmaceuticals.
In  2005,  Chambliss  and  Brooks  were 
part  of  the  first  team  to  document  sub­
stantial  uptake  of  pharmaceuticals  in  fish, 
and  experts  agree  their  latest  findings  are 
consistent with the work conducted to date 
by a number of scientists. Moreover, the find­
ings  have  inspired  the  EPA,  which  funded 
the  research,  to  expand  its  investigation  of 
PPCPs in fish under its National Rivers and 
Streams Assessment to obtain a more detailed 
national perspective, says Suzanne Rudzinski, 
deputy director of the EPA Office of Science 
and Technology. The agency is investigating 
whether the concentrations of pharmaceuti­
cals present in fish are of concern for human 
health or for the fish themselves, she says.
The  very  low  concentrations  of  phar­
maceuticals  in  the  fish  flesh  may  translate 
into “good news for public health concerns,” 
says Shane Snyder, a project manager at the 
Southern Nevada Water Authority’s Applied 
Research  and  Development  Center.  “You’d 
have to eat tons of fish to come even close to 
the  pharmaceutical  levels  we  predict  would 
be  of  concern  to  human  health,”  he  says. 
He  also  points  out  that  effluent­dominated 
waterways constitute an “amazing minority” 
of U.S. streams.
Dana  Kolpin,  a  project  chief  with  the 
USGS Toxic Substances Hydrology Program, 
is  more  cautious,  however.  “What  if  these 
compounds bioaccumulate in tissue or have 
unintended consequences from the complex 
mixtures of contaminants we’re exposed to?” 
he asks. Moreover, he says, “USGS research 
has shown that PPCPs are commonly present 
in streams across the United States, not just 
those that are truly effluent­dominated. While 
these results in effluent­dominated 
streams may be the extreme case, 
this  will  not  be  the  only  setting 
where such PPCPs will be found in 
fish tissue.” 
Last year, Kolpin and colleagues 
reported  in  the  15  March  2008 
issue  of  Environmental  Science  & 
Technology that earthworms can take 
up  PPCPs  from  biosolids  applied 
on  land.  Considered  together,  the 
research  to  date  begs  for  further 
study into the potential impacts of 
such  chemical  mixtures  on  both 
aquatic and terrestrial organisms, he 
says. This is particularly true because 
researchers’ analytical methods allow 
them to look for only a few hundred 
of  the  thousands  of  PPCPs  that 
might be in U.S. water bodies, adds 
Herb  Buxton,  coordinator  for  the 
USGS Toxic Substances Hydrology 
Program.
Comparing personal care prod­
ucts  and  pharmaceuticals,  Snyder 
says  the  former  may  merit  greater 
investigation—some of the concen­
trations documented by Chambliss 
and  Brooks  for  these  compounds 
are orders of magnitude higher than 
those  seen  for  pharmaceuticals. 
For  example,  the  highest  uptake 
reported  in  the  study  was  of  the 
synthetic fragrance galaxolide, which 
showed a maximum concentration of 
2,100 ng/g in fish fillets (sertraline, 
Turn on your tap and get hot- and cold-running crud.
Tom Lehrer, songwriter/satirist, “Pollution”
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Compound Use
≥ MDL
in Liver
≥ MDL
in Fillet
Fluoxetine Antidepressant yes no
Norfluoxetine Antidepressant yes yes
Sertraline Antidepressant yes yes
Diphenhydramine Antihistamine yes yes
Diltiazem Antihypertensive yes yes
Atenolol Antihypertensive no no
Metoprolol Antihypertensive no no
Propanolol Antihypertensive no no
Carbamazepine Antiseizure yes yes
Triclosan Antimicrobial no no
Galaxolide Fragrance no yes
Tonalide Fragrance no yes
Celestolide Fragrance no no
Gemfibrozil Lipid regulator yes no
1,7 Dimethylxanthine Antispasmodic no no
Acetaminophen Analgesic no no
Ibuprofen Analgesic no no
Caffeine Stimulant no no
Cimetidine Anti–acid reflux no no
Codeine Analgesic no no
Erythromycin Antibiotic no no
Lincomycin Antibiotic no no
Sulfamethoxazole Antibiotic no no
Trimethoprim Antibiotic no no
Tylosin Antibiotic no no
Miconazole Antifungal no no
Thiabendazole Antifungal no no
Warfarin Blood thinner no no
4-Methylbenzylidene   
  camphor
Ultraviolet filter no no
Octocrylene Ultraviolet filter no no
m-Toluamide Insect repellant no no
Musk ketone Fragrance no no
Musk xylene Fragrance no no
Nonylphenol Surfactant no no
Octylphenol Surfactant no no
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endocrine disruptors
Estrogens 
in a Bottle? 
Much  of  our  exposure 
to  endocrine  disruptors 
occurs  through  what  we 
eat and drink—in some 
cases,  chemicals  such 
as  plasticizers  may  have 
migrated  from  food  or 
beverage packaging. The 
possibility  that  these 
chemicals end up in com­
monly  consumed  bever­
ages was the focus of two 
recent European studies that found evidence of 
estrogenic activity in mineral water. Both stud­
ies focused on the estrogenic potential of min­
eral water bottled in polyethylene terephthalate 
(PET) plastic, the material constituting most 
convenience­size beverage bottles sold in the 
United States today.
In the first study, published in the March 
2009  International  Journal  of  Hygiene  and 
Environmental  Health,  a  recombinant  yeast­
based in vitro assay was used to assess estro­
genic activity in 30 PET­bottled mineral water 
samples. Ninety percent of the samples tested 
negative for estrogenic activity. Of the remain­
ing samples, most showed measurements cor­
responding to a range of 14–23 ng/L estradiol 
equivalents—similar  to  the  estrogen  burden 
posed by treated drinking water derived from 
groundwater and river water (15 and 17 ng/L 
estradiol equivalents, respectively).
Of the estrogen­positive samples, authors 
Barbara  Pinto  and  Daniela  Reali,  investiga­
tors in the University of Pisa Department of 
Experimental Pathology, say the water may 
have been contaminated at its source, during 
processing, or after bottling. They cite several 
studies showing that suboptimal storage condi­
tions—such as prolonged exposure to sunlight 
and  high  temperatures—can  cause  leaching 
of  chemicals  from  PET  bottles  into  fluid 
contents, and point out that “cell toxicity was 
observed for water samples of 
the same lot of three different 
brands  purchased  from  the 
same retailer.”
Estrogenic activity in 
PET­bottled  mineral  water 
was also observed by graduate 
student Martin Wagner and 
chairman Jörg Oehlmann 
of the Department of 
Aquatic  Ecotoxicology  at 
Johann Wolfgang Goethe 
University. Using a similar 
but  more  sensitive  yeast­
based  estrogen  screen,  the 
researchers tested 20 brands 
of  mineral  water  packaged 
in PET, glass, or coated paperboard. Elevated 
estrogenic  activity  was  measured  in  12  of 
20 brands of mineral water, including 78% 
of those bottled in PET and 33% of those 
bottled  in  glass.  However,  multiuse  PET 
bottles (which are intended to be reused sev­
eral times) showed lower estrogenicity than 
bottles  meant  for  one­time  use—and  were 
even lower than glass bottles from the same 
mineral water source.
This study, published online 10 March 
2009 in Environmental Science and Pollution 
Research, also included experiments in which 
mud snails (Potamopyrgus antipodarum), an 
organism that is highly sensitive to estrogens, 
were raised in glass and PET bottles. The 
findings mirrored those from the yeast­based 
assay, but with one interesting exception: A 
PET sample that showed minimal response 
in the yeast assay induced one of the more 
significant results in the mud snail assay.
The disparity implies bottled water may 
contain a mix of compounds. “Perhaps the 
snails were reacting to, for example, anti­
androgens coming from these plastic bot­
tles. We would have missed these in vitro 
because we only looked for [estrogen recep­
tor]  ligands,”  Wagner  says.  Although  he 
and Oehlmann also noted several points at 
which contamination could have occurred 
during water processing, Wagner says the 
snail data led them to conclude that at least 
some  contamination  arose  from  the  PET 
bottles: “Because the snail experiment did 
not use mineral water but rather a defined 
culture medium for snails, which was the 
same in all bottles, the estrogenic effect in 
the snails could only have come from the 
packaging material.”
This  conclusion  has  been  strongly  dis­
counted by several industry groups, including 
the PET Resin Association (PETRA). “It has 
been demonstrated through extensive studies 
that PET meets all established safety standards 
for use in food and beverage packaging and 
has  been  safely  used  for  that  purpose  for 
decades,” says Ralph Vasami, executive direc­
tor of PETRA. The organization also empha­
sizes that PET destined for food and beverage 
containers  does  not  contain  bisphenol  A  or 
orthophthalates,  both  of  which  have  been 
heavily scrutinized as endocrine disruptors. 
Still,  we  should  think  about  the  com­
ponents of PET plastic in terms of potential 
leaching of products that have biological activ­
ity, says Kris Thayer, a staff scientist at the 
National Toxicology Program’s Center for the 
Evaluation of Risks to Human Reproduction, 
in response to the Italian and German studies. 
“If people are moving away from polycarbon­
ate  plastics  [due  to  bisphenol  A  concerns], 
what do they use instead? When we consider 
alternative plastics, we need to be sure they 
are characterized,” she says. Part of the char­
acterization process entails finding out which 
compounds, if any, leach from the plastic. 
Neither  of  the  European  studies  can 
be  used  to  deduce  anything  about  poten­
tial  human  health  effects  of  drinking  PET­
bottled  beverages.  However,  if  PET  bottles 
do leach endocrine­disrupting chemicals into 
the beverages they contain, it could represent 
a  significant  source  of  exposure  for  many 
people. According to figures from the Beverage 
Marketing Corporation published in the April/
May  2009  issue  of  Bottled  Water  Reporter, 
Americans drank 108 L of bottled water per 
person in 2007, while per­capita Italian con­
sumption reached 204 L. –Julia R. Barrett
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the pharmaceutical consistently found at the 
highest  concentrations,  was  detected  in  fillet 
and liver at 19 and 545 ng/g, respectively). The 
research  literature  makes  it  “pretty  clear  that 
[personal care products] are bioaccumulating,” 
Snyder  says,  adding  that  people  often  spray 
fragrance compounds all over themselves.
Larsson points out that although drugs are 
specifically designed to interfere with biologi­
cal systems, synthetic musk fragrances are not. 
“Thus, even if levels are higher of the musks, 
it is not clearcut that the risks are higher with 
this group of chemicals,” he says.
Potential  concerns  raised  by  the  new 
study include possible impacts on aquatic life 
in light of growing evidence that very low­
level exposure to pharmaceuticals can impact 
fish and other underwater dwellers, Brooks 
and Kolpin point out. In time, research on 
the  effects  of  PPCP  exposure  may  inspire 
scientists  to  come  up  with  new  ways  to 
conduct  ecologic  risk  assessments,  Brooks 
predicts. “Risk assessments are based on tra­
ditional responses in fish, such as changes in 
growth or survival, that we may not see when 
they’re exposed to PPCPs,” points out Karen 
Kidd, a biologist with the University of New 
Brunswick’s  Canadian  Rivers  Institute.  For 
example,  some  PPCPs  affect  immune  sys­
tem function or behavior, responses that risk 
assessments don’t currently include, she says.
“The current testing approaches are not 
sufficiently  optimized  for  efficiently  finding 
either the species, the endpoints, or the drugs 
that are probably of most concern,” Larsson 
adds. He and Kidd agree that the new pilot 
study’s effort to document which compounds 
are taken up by exposed fish is an important 
step in the right direction. –Kellyn S. Betts
PET-housed snails produced 
up to twice as many embryos 
as glass-housed snails.L
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More Weight, More Allergies?
A study co-funded by the NIEHS and the NIAID 
suggests a possible connection between rising 
rates of childhood obesity and allergies over 
the past few decades. Analyzing 2005–2006 
NHANES data, the researchers reported in 
the May 2009 Journal of Allergy and Clinical 
Immunology that obese children were 26% 
more likely than children of normal weight to 
have allergies and 59% more likely to have 
a food allergy. Although an increased risk of 
allergy might not be the most serious health 
problem faced by overweight children, it 
does provide an added incentive for stepping 
up efforts to prevent childhood obesity, the 
researchers contend. 
Some “Lead-Free” Pots Are Not
Traditional lead-glazed pottery from Mexico 
has been cited as a common source of lead 
exposure among people who use these wares. 
A study by the Environmental Quality Institute 
at the University of North Carolina at Asheville 
showed that Mexican-made “Mi Pueblo” brand 
clay pots marketed in some eastern U.S. states 
as “lead-free” actually contained nearly twice 
the amount of lead considered safe by the FDA 
for cups, mugs, and pitchers, and just under 
the safe level for serving bowls. Ironically, the 
researchers had hoped to confirm the safety of 
Mi Pueblo products to enable their promotion 
as a safe alternative to lead-glazed pots. 
Massive Bloom the New Norm?
In summer 2008 an unprecedented algal bloom 
almost caused the cancellation of the Olympic 
Games’ sailing events in the regatta city of 
Qingdao, China. It took more than 10,000 
people to clean up over 1 million tons of 
Enteromorpha prolifera algae from the beach 
and coast. Initially attributed to eutrophication, 
a study in the June 2009 Marine Pollution 
Bulletin now suggests a different provenance 
The Beat | by Erin E. Dooley
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Harmful algal Blooms
An Unexpected Deep-Sea 
Diver
Domoic acid (DA), a potent neurotoxin produced primarily by 
the diatom genus Pseudo-nitzschia, is generated during harmful 
algal blooms—rapid surges in toxic algae populations that result 
from  increases  in  nutrient  availability,  temperature,  and  sun­
light, among other environmental changes. Previously, scientists 
assumed that once the blooms dissipated, DA was released into 
and diluted within the upper ocean layer. But a study published 
in the April 2009 issue of Nature Geoscience shows that DA can 
be trapped inside the silica shells of Pseudo-nitzschia and carried 
to the ocean floor. Concentrations of DA in particles collected in 
deep oceans were several times higher than the regulatory limit set 
by the U.S. Environmental Protection Agency (EPA) to prevent 
human poisoning. 
DA can cause a condition called amnesic shellfish poisoning in 
people  who  eat  contaminated  crabs,  oysters,  clams,  mussels,  scal­
lops, anchovies, and sardines—all of which feed on Pseudo-nitzschia. 
Symptoms include gastrointestinal upset, headache, dizziness, cardiac 
arrhythmia, coma, potential loss of short­term memory, and possibly 
death. Water­soluble DA concentrates in the stomachs of shellfish 
and tiny fish. To ingest DA, people must eat the whole organism, 
including the stomach, says Stephen Bates, phyto  plankton scientist 
emeritus with Fisheries and Oceans Canada. 
Although  elderly  people  are  considered  the  most  vulnerable 
to the effects of DA, early­life exposures also may be problematic. 
Recent  rodent  studies  by  biologists  at  the  University  of  Prince 
Edward  Island,  published  in  the  23  March  and  16  April  2009 
issues of Physiology & Behavior, found that neonatal exposure to 
low doses of DA was associated with lasting cognitive deficits and 
behavioral problems in adult animals. Moreover, findings reported 
in the December 2008 issue of Marine Drugs suggest DA may be 
immunotoxic in mice.
For the current study, researchers set up sediment traps off the coast 
of Southern California, where Pseudo-nitzschia blooms and DA poison­
ing are prevalent. The traps floated above the sea floor at depths of 540, 
550, and 800 m. Sediment collected in traps set at 550 m contained 
up to 50 μg DA/g dry sediment, and traps set at 800 m contained up 
to 163 μg DA/g of dry sediment. Measurements showed that DA sank 
rapidly, settling to 800 m in about three days. Bates says shellfish and 
sediment levels are not directly comparable because the former reflects 
wet weight, whereas the latter reflects dry weight, but that a rough com­
parison can be made for the purpose of assessing relative amounts.
The findings suggest that marine creatures living in deeper waters 
may be contaminated with DA, yet health officials currently moni­
tor only shellfish that live close to the surface. The U.S. EPA and the 
Canadian Food Inspection Agency regularly check commercial shellfish 
beds, with increased testing during algal blooms, closing the beds when 
levels reach 20 μg DA/g tissue. However, says study leader Claudia 
Benitez­Nelson, a geochemist at the University of South Carolina, 
“We no longer can use algal blooms as an indicator of [potential] DA 
poisoning.”
The fact that DA sinks to deeper waters may, in fact, help explain 
past  mysterious  outbreaks  of  shellfish  poisoning.  For  instance,  in 
1995 lucrative deep­sea scallop beds were closed to harvesting off the 
coast of Nova Scotia in the Gulf of Maine. The scallops contained 
up to 3,400 μg DA/g tissue. “We didn’t know where the DA came 
from,” Bates says. “But the new data suggest that the cause could have 
been DA sinking down from surface blooms of Pseudo-nitzschia.” 
The key to curbing DA poisoning is to understand why and 
when Pseudo-nitzschia blooms occur. Although harmful algal blooms 
are mainly viewed as natural phenomena, the magnitude and occur­
rence of some toxic species can be exacerbated by nutrient inputs 
from human sewage and fertilizer and possibly other forms of coastal 
pollution. “People are working hard to reduce runoff from crops 
and lawns, but it takes time,” says Benitez­Nelson. Meanwhile, she 
adds, “Once [Pseudo-nitzschia] bloom, it’s very difficult to control the 
toxins they produce.” –Carol Potera
Military officers clean up the 
Qingdao algal bloom, July 2008cHildren’s HealtH
Gene Variants May Predict 
Lung Health
Genetic research is beginning to provide potential insights on why 
some people are more vulnerable than others to various pollutants. 
Now a few more pieces can be added to the extraordinarily com­
plex puzzle. In the April 2009 American Journal of Respiratory and 
Critical Care Medicine, researchers from the University of Southern 
California  report  that  several  inherited  glutathione S­transferase 
(GST) gene variants were associated with lung function growth dur­
ing adolescence, and one variant helped predict poor lung function in 
children whose mothers had smoked during pregnancy.
GST genes are expressed in the lungs, among other organs, and 
may influence the development of normal lung function. This study 
focused on a class of GST genes called GSTMs. The best studied of 
these is GSTM1, which has been implicated in lung cancer, asthma, 
and other respiratory diseases in children and adults. To find out more 
about other variants, the authors looked at GSTM2, GSTM3, GSTM4, 
and GSTM5. They analyzed the genotypes in conjuction with eight 
years’  worth  of  lung  function  and  genotyping  data  from  2,108 
Southern California schoolchildren, starting around age 10 years. 
For GSTM2, two common haplotypes (patterns of genetic varia­
tion) were observed. One haplotype found in 28% of non­Hispanic 
whites and 44% of Hispanic whites was associated with better lung 
development  than  other  haplotypes,  whereas  a  second  haplotype 
found in 35% of non­Hispanic whites and 30% of Hispanic whites 
was associated with significantly less lung function growth over time. 
Deficits in measures of lung function growth were twice as big in 
children with two copies of the haplotype versus those with one copy, 
and the deficits associated with this haplotype were greater among 
children of mothers who smoked during pregnancy.  
The  presence  of  a  GSTM4  haplotype  found  in  22%  of  non­
Hispanic whites and 16% of Hispanic whites was associated with sig­
nificantly reduced lung function growth relative to children with other 
haplotypes. As with the GSTM2 variant above, deficits in lung function 
growth were doubled among children with 2 copies of the haplotype. 
A GSTM3 haplotype found in about 7% of the children was associated 
with a deficit in one of three measures of lung function growth. 
The authors believe this to be the first study to report evidence of 
an interaction between GSTM2 variants and prenatal tobacco smoke 
exposure on lung function growth. They noted that GSTM genes are 
expressed in fetal tissue at relatively low levels, and GSTs and other 
phase II (detoxification) enzymes are relatively inactive in fetal tissue 
compared with phase I enzymes (which activate toxic metabolites and 
carcinogens). “This suggests that fetuses are much more susceptible 
to environmental exposures than adults,” they wrote. “Genetic poly­
morphisms in phase II enzymes that further inhibit enzyme activity 
may exacerbate this susceptibility.” In addition, respiratory health and 
development in childhood is known to play an important role in adult 
respiratory health.
This study “points out again that the genetic makeup of a popu­
lation  may  be  very  important  when  considering  health  risks  from 
environmental exposures,” says principal investigator Frank Gilliland, 
who directs the NIEHS­supported Southern California Environmental 
Health Sciences Center at the University of Southern California. His 
team  speculates  that  GSTM­influenced  failure  to  detoxify  reactive 
oxygen species reduces lung protection and triggers an inflammatory 
cascade, bronchial constriction, and airway hyperresponsiveness, pro­
ducing asthma­like symptoms and impaired lung development. 
However,  more  information  would  be  needed  before  public 
health  officials  could  set  or  adjust  regulatory  standards  based  on 
variation  in  vulnerability  among  subpopulations.  And  even  with 
such additional data, Medea Imboden, a molecular epidemiologist at 
the University of Zürich, cautions against overemphasizing the GST 
gene family. “You always have doubts about the functional relevance 
of the variants,” says Imboden. “If you think of all the genes not yet 
known to contribute to respiratory health and bodily defense systems 
against air pollutants, GSTs might turn out to play a minor role.” But 
for now, she adds, “they are good candidates.” –Bob Weinhold
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for the bloom. The authors used satellite 
images to trace the bloom’s origin to the 
coast of Jiangsu province, where E. prolifera 
contaminates aquaculture operations that 
grow Porphyra seaweed for food. With the 
aquaculture industry off Jiangsu’s coast having 
more than doubled in size since 2003, the 
authors say the stage is set for more massive 
blooms such as the one seen in Qingdao. 
Carbofuran Banned for Food Crops
On 11 May 2009 the EPA revoked regulations 
that allowed small residues of the pesticide 
carbofuran on food crops, saying the compound 
poses an unacceptable health risk, especially to 
children and farmworkers. The move came after 
years of review, a partial ban in the mid-1990s 
(when millions of migratory bird deaths were 
linked to carbofuran), and an attempt earlier in 
2009 by the chemical’s manufacturers to delay 
further restrictions. The EPA cited unacceptable 
neurotoxicity and other health risks posed by 
ingesting residues of the insecticide in food and 
water. The final carbofuran tolerance rule takes 
effect in December 2009. 
BPA Becoming Chemical Non Grata
In May 2009 Chicago and Minnesota became 
the first city and state, respectively, to ban 
bisphenol  A  (BPA)  in  baby  bottles  and 
children’s cups. Lawmakers in Connecticut 
and California are now considering similar 
BPA regulations. On the federal level, bills 
aimed at banning BPA from all food and 
beverage containers were introduced in the 
House and the Senate in March 2009 but 
are still in committee. BPA is found in some 
polycarbonate plastic containers such as water 
and baby bottles and in some food can linings. 
BPA is weakly estrogenic, and numerous animal 
studies suggest exposure to the compound 
during critical developmental windows may 
contribute to adverse reproductive, behavioral, 
and metabolic effects.  
Bad Air Rising
Six of 10 U.S. citizens, or more than 186 million 
people, reside in areas with dangerous levels of 
air pollution, according to the American Lung 
Association’s State of the Air: 2009 report. 
Although some major U.S. cities have improved 
their air quality over the last decade, the air in 
many other cities became more polluted last 
year. The 2009 figures are substantially higher 
than those from 2008, when an estimated 42% 
of the population faced similar conditions. The 
report includes a call for the EPA to strengthen 
its standards for ozone and particulate matter. 
The agency issued new ozone standards in 
2008, and proposed revisions to particulate 
matter standards are due in 2010. 
Forum
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